Invention Grant
- Patent Title: Use of tangeretin in cancer treatment
-
Application No.: US14848360Application Date: 2015-09-09
-
Publication No.: US09808439B2Publication Date: 2017-11-07
- Inventor: Wen-zhe Ma , Sen-ling Feng , Xiao-jun Yao , Zhong-wen Yuan , Liang Liu , Ying Xie
- Applicant: Macau University of Science and Technology
- Applicant Address: CN Macau
- Assignee: Macau University of Science and Technology
- Current Assignee: Macau University of Science and Technology
- Current Assignee Address: CN Macau
- Agency: Eagle IP Limited
- Agent Jacqueline C. Lui
- Main IPC: A61K31/352
- IPC: A61K31/352 ; A61K31/337 ; A61K45/06 ; A61K31/704
Abstract:
The present invention discloses a pharmaceutical composition of treating multidrug resistance cancer, comprising a citrus methoxyflavone and a chemotherapeutic drug, in which the citrus methoxyflavone is tangeretin. A method of treating multidrug resistance cancer comprising administrating citrus methoxyflavone and a chemotherapeutic drug is also disclosed.
Public/Granted literature
- US20170027900A1 USE OF TANGERETIN IN CANCER TREATMENT Public/Granted day:2017-02-02
Information query
